Listed

Mesoblast Ltd: Form 20-F for the period ended Jun 30, 2026

Filed with the SEC on Aug 27, 2026 and accepted by EDGAR at Aug 27, 2026, 06:08 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2026-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Shares outstandingAt period end2026-06-301,296,862,776 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001345099-26-000081. Last ingested by Listed: Oct 29, 2026, 06:58 ET. Listed shows no prices and gives no investment advice.